{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-023707","form_type":"8-K","ticker":"ABCL","cik":"0001703057","company_name":"AbCellera Biologics Inc.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.903629+00:00","generated_at":"2026-06-25T00:27:56.597842+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"AbCellera shareholders elect Hansen and Hayden as Class II directors at annual meeting","bullets":["Carl G. Hansen re-elected with 140.1M for, 32.2M against; Michael Hayden elected with 147.0M for, 25.3M against.","KPMG ratified as independent auditor for FY 2022: 202.0M for, 0.4M against, 10.7M abstain.","Non-binding say-on-pay approved: 167.8M for, 4.4M against, 10.7M abstain.","Advisory vote favored one-year frequency for future say-on-pay: 171.7M for one year.","Total outstanding shares: 284.5M; broker non-votes of 30.2M on director and say-on-pay proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-023707","json":"https://secwatch.observer/filing/0001564590-22-023707.json","markdown":"https://secwatch.observer/filing/0001564590-22-023707.md","text":"https://secwatch.observer/filing/0001564590-22-023707.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/0001564590-22-023707-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/abcl-8k_20220615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:27:56.597842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}